MedCity News July 18, 2024
Carmine DeNardo

In addition to increasing medication access for underserved populations, an in-house specialty pharmacy improves patient care and provides opportunities for efficiency and enhancement across hospital operations.

Hospital operating margins in recent months have started rebounding. However, persistent challenges such as staffing shortages and rising expenses leave providers’ financial health uncertain. Hospital leaders must find new revenue streams to weather financial headwinds, and the increasing demand for specialty drugs is an opportunity to boost revenues through entity-owned specialty pharmacy.

The demand for specialty drugs is reaching new heights as 60% of Americans have a chronic disease requiring these more complex therapies and 14 million more Americans are projected to be diagnosed with chronic medical conditions between 2020 and 2030. This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Pharma / Biotech, Provider
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations
Healthcare leaders urge Congress to recognize pharmacists as providers
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article